Navigation Links
FDA's DDMAC Provides Insight on Pharmaceutical Companies and Web 2.0 in Eye on FDA Podcast
Date:3/17/2009

Eye on FDA, a specialty blog written by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., posts an interview with the new official at FDA's DDMAC in charge of Web 2.0 policy development providing insight into FDA's point of view about the use of New and Social Media in Web 2.0 by the pharmaceutical industry.

Washington, DC (PRWEB) March 17, 2009 -- Today Eye on FDA, a specialty blog written by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., posted a podcast recorded at the FDA on March 11, 2009 that interviews Dr. Jean Ah Kang, the official at FDA's DDMAC who is in charge of policy development with respect to pharmaceutical company use of new and social media in Web 2.0 marketing and communications efforts.

The pharmaceutical industry has been slow to embrace Web 2.0 because of regulatory concerns that reaching out to patients using social and digital media might provoke action by the FDA's Division of Drug Marketing Advertising and Communications (DDMAC). To date, the FDA has relied on traditional regulatory principles in evaluating pharmaceutical company use of Web 2.0 but has provided little insight on the agency's thinking of the many evolving communications in digital and social media.

Today, Eye on FDA posted Mark Senak's podcast interview with Dr. Jean Ah Kang, Special Assistant to DDMAC head Tom Abrams, who is in charge of the development of Web 2.0 policy for the FDA. They discussed whether or not the current regulatory environment prohibits pharmaceutical involvement in Web 2.0; what kind of considerations pharmaceutical companies need to consider; FDA's thoughts on specific situations involving social and digital media use; and how companies considering digital strategies should approach the FDA for input. It may well be the most complete public statement by the FDA on the topic to date.

Makr Senak's Eye on FDA

'Eye on FDA' has a diverse 'readership', including national media, government officials, patient groups, law firms, stock analysts and pharmaceutical companies themselves.

###

Read the full story at http://www.prweb.com/releases/fda-podcast-senak/32009/prweb2239614.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... established the certification process to promote standards of excellence for the field of ... scheduled for March 22 – 25, 2018 in Orlando, Florida at the Omni ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance in ... medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative ... into a clinical solution to support the improvement of patient outcomes, ... Design ... Solution ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
Breaking Medicine Technology: